New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

FMEDvsWDNAETF Comparison

ETF 1
FMED

Fidelity Disruptive Medicine ETF

This fund is part of
Multiple Trends
+2.93%
VS
ETF 2
WDNA

WisdomTree BioRevolution Fund

This fund is part of
BioTech & Genomics
+0.66%

Fidelity Disruptive Medicine ETF (FMED) belongs to the Multiple Trends segment. WisdomTree BioRevolution Fund (WDNA) is part of the BioTech & Genomics segment. FMED's top 1 sector exposures are Healthcare. In contrast, WDNA's top sector exposures are Healthcare, Non-Energy Materials and Consumer Non-Cyclicals. FMED is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.45% for WDNA. FMED is up 17.43% year-to-date (YTD) with -$17M in YTD flows. WDNA performs better with 38.71% YTD performance, and +$1M in YTD flows. Run a side-by-side ETF comparison of FMED and WDNA below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FMED vs WDNA performance and flow charts

Performance

-6.0-4.0-2.00.02.0%Aug 21Aug 28Sep 4Sep 14Sep 21

Cumulative Flows

0 M0.5 M1 M1.5 MAug 21Aug 28Sep 4Sep 14Sep 21

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/21/2026
1M3MYTD1Y3Y5Y
Perf.
FMED
WDNA
-2.40%-0.68%
+21.48%+23.59%
+17.43%+38.71%
+29.04%+61.24%
+43.82%+62.78%
n/a-6.36%
Flows
FMED
WDNA
-+$2M
-+$2M
-$17M+$1M
-$14M+$1M
-$3M+$1M
-+$3M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FMED
WDNA
+24.66%+34.78%
+21.06%+27.97%
+19.25%+26.37%
n/a+25.78%
Max drawdown
FMED
WDNA
-7.15%-9.35%
-17.78%-11.90%
-19.20%-36.45%
n/a-57.38%
Max drawdown duration
FMED
WDNA
29d42d
212d147d
267d595d
n/a1824d
Trading data

Create an account to view trading data

Join for free
FMED
WDNA
Last sale
9/22/2026 at 1:30 PM
$23.92
Previous close
09/21/2026
$23.43
Consolidated volume
09/21/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 22, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

FMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
FMED
WDNA
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/22/2026 at 1:30 PM
Live
Closed
FMED
WDNA
Last price
$23.92
1D performance
+2.08%
AuM$51.66 M$4.69 M
E/R0.5%0.45%
Characteristics
FMED
WDNA
Management strategyActivePassive
ProviderFidelityWisdomTree
Benchmark-WisdomTree BioRevolution Index
N° of holdings7479
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateJune 12, 2023June 3, 2021
ESGNoNo
Advertisement
Exposure

Countries

FMED
USA
83.4%
Other
16.6%
WDNA
USA
83.75%
Other
16.25%

Sectors

FMED
Healthcare
100%
Other
0%
WDNA
Healthcare
88.38%
Non-Energy Materi.
7.38%
Other
4.25%

Diversification

FMED

Total weight of top 15 holdings out of 15

43.09%
WDNA

Total weight of top 15 holdings out of 15

40.46%

Top 15 holdings

Data as of July 31, 2026
FMED
10X Genomics, Inc.
4.48%
Thermo Fisher Scientific, Inc.
3.98%
Danaher Corp.
3.86%
Lifestance Health Group, Inc.
3.15%
Alnylam Pharmaceuticals, Inc.
3.10%
argenx SE
2.99%
Cogent Biosciences, Inc.
2.98%
Revolution Medicines, Inc.
2.85%
Illumina, Inc.
2.62%
Intuitive Surgical, Inc.
2.34%
Kymera Therapeutics, Inc.
2.29%
UnitedHealth Group, Inc.
2.24%
Ascendis Pharma A/S
2.12%
Kiniksa Pharmaceuticals International Plc
2.06%
UCB SA
2.03%
WDNA
Twist Bioscience Corp.
5.53%
Eli Lilly & Co.
4.11%
Moderna, Inc.
3.59%
Johnson & Johnson
3.13%
Immunome, Inc.
2.57%
United Therapeutics Corp.
2.50%
10X Genomics, Inc.
2.44%
Natera, Inc.
2.42%
Darling Ingredients, Inc.
2.26%
Corteva, Inc.
2.19%
Structure Therapeutics, Inc.
2.04%
Stoke Therapeutics, Inc.
2.02%
Krystal Biotech, Inc.
2.01%
Thermo Fisher Scientific, Inc.
1.83%
Tempus AI, Inc.
1.82%
Frequently asked questions about FMED and WDNA

How have the FMED and WDNA ETFs performed in 2026?

As of September 21, 2026, FMED is up 17.43% year-to-date (YTD), while WDNA has returned 38.71%. That puts WDNA better performer ahead so far this year.

Which ETF is attracting more investor money: FMED or WDNA?

Year-to-date, the FMED ETF saw -$17M in flows, compared to +$1M for WDNA.

Which ETF is more volatile: FMED or WDNA?

Over the past year, FMED had a volatility of 21.06%, while WDNA experienced 27.97%.

Which ETF is bigger: FMED or WDNA?

As of September 21, 2026, FMED holds $51.66 M in assets under management (AUM), while WDNA manages $4.69 M.

What sectors do the FMED and WDNA ETFs invest in?

FMED leans toward sectors like Healthcare. Meanwhile, WDNA focuses on Healthcare and Non-Energy Materials.

What are the top holdings of the FMED ETF and WDNA ETF?

FMED top holdings include 10X Genomics, Inc., Thermo Fisher Scientific, Inc. and Danaher Corp.. WDNA holds in its top three: Twist Bioscience Corp., Eli Lilly & Co. and Moderna, Inc..

Which ETF is more diversified: FMED or WDNA?

FMED holds 74 securities with 43.09% of its assets in the top 15. WDNA has 79 securities and a top 15 weight of 40.46%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder